tiprankstipranks
Advertisement
Advertisement

GB:VAL Stock Latest News

ValiRx updates registered office as it advances oncology and women’s health focus
Company AnnouncementsValiRx updates registered office as it advances oncology and women’s health focus
11d ago
ValiRx trims costs and expands oncology pipeline with new human and veterinary initiatives
PremiumCompany Announcements
ValiRx trims costs and expands oncology pipeline with new human and veterinary initiatives
16d ago
ValiRx gains oncology spotlight with digital twin data and expanding scientific footprint
PremiumCompany Announcements
ValiRx gains oncology spotlight with digital twin data and expanding scientific footprint
18d ago
ValiRx CEO Increases Stake with 1 Million-Share Purchase
PremiumCompany Announcements
ValiRx CEO Increases Stake with 1 Million-Share Purchase
1M ago
ValiRx launches veterinary oncology arm to tap fast-growing animal cancer market
PremiumCompany Announcements
ValiRx launches veterinary oncology arm to tap fast-growing animal cancer market
1M ago
ValiRx Issues 80,000 New Shares Following Warrant Exercise
PremiumCompany AnnouncementsValiRx Issues 80,000 New Shares Following Warrant Exercise
3M ago
ValiRx Strikes RNA Helicase Deal with McGill and IRICoR Under Asset-Focused Funding Model
Premium
Company Announcements
ValiRx Strikes RNA Helicase Deal with McGill and IRICoR Under Asset-Focused Funding Model
3M ago
ValiRx Strikes RNA Helicase Inhibitor Deal with McGill and IRICoR to Drive Asset-Level Growth
Premium
Company Announcements
ValiRx Strikes RNA Helicase Inhibitor Deal with McGill and IRICoR to Drive Asset-Level Growth
3M ago
ValiRx Advances with New Equity and Warrant Issuance Post-General Meeting
PremiumCompany Announcements
ValiRx Advances with New Equity and Warrant Issuance Post-General Meeting
5M ago
ValiRx PLC Announces Fundraising to Boost Cancer and Women’s Health Research
PremiumCompany Announcements
ValiRx PLC Announces Fundraising to Boost Cancer and Women’s Health Research
5M ago
ValiRx PLC Raises £902,000 Through Successful Fundraising
PremiumCompany Announcements
ValiRx PLC Raises £902,000 Through Successful Fundraising
5M ago
ValiRx Plc Raises £902,000 Through Successful WRAP Retail Offer
PremiumCompany Announcements
ValiRx Plc Raises £902,000 Through Successful WRAP Retail Offer
5M ago
ValiRx Plc Launches £300,000 Retail Offer to Boost Cancer Therapeutics Development
PremiumCompany AnnouncementsValiRx Plc Launches £300,000 Retail Offer to Boost Cancer Therapeutics Development
5M ago
ValiRx PLC Launches £1.05 Million Fundraising to Boost Cancer and Women’s Health Initiatives
Premium
Company Announcements
ValiRx PLC Launches £1.05 Million Fundraising to Boost Cancer and Women’s Health Initiatives
5M ago
ValiRx PLC Advances Cancer Therapeutics with Strategic Partnerships and Innovations
Premium
Company Announcements
ValiRx PLC Advances Cancer Therapeutics with Strategic Partnerships and Innovations
6M ago
ValiRx Reports Strategic Advancements and Cost Efficiency in H1 2025
PremiumCompany Announcements
ValiRx Reports Strategic Advancements and Cost Efficiency in H1 2025
6M ago
ValiRx Advances Cancer Therapeutics with Digital Twin Collaboration
PremiumCompany Announcements
ValiRx Advances Cancer Therapeutics with Digital Twin Collaboration
7M ago
ValiRx’s Cytolytix Advances Cancer Therapeutics with Key Patent and Platform Developments
PremiumCompany Announcements
ValiRx’s Cytolytix Advances Cancer Therapeutics with Key Patent and Platform Developments
7M ago
ValiRx Expands Prostate Cancer Portfolio with New Subsidiary
PremiumCompany Announcements
ValiRx Expands Prostate Cancer Portfolio with New Subsidiary
8M ago
ValiRx Secures Grant to Advance Cancer Research with Open University
PremiumCompany AnnouncementsValiRx Secures Grant to Advance Cancer Research with Open University
8M ago
ValiRx Updates Evaluation Agreement with Stingray Bio for Cancer Therapeutics
Premium
Company Announcements
ValiRx Updates Evaluation Agreement with Stingray Bio for Cancer Therapeutics
8M ago
ValiRx Enters Licensing Agreement with Dominion Biotech for PredictRx Platform
Premium
Company Announcements
ValiRx Enters Licensing Agreement with Dominion Biotech for PredictRx Platform
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >